← SynDRA
ZERANOL
SynDRA canonical compound SYN0012115 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ACTA2 | ESR1 | NR1I2 | SHBG |
|---|
| Mechanism of action | estrogen receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ESR2
- ALDH1A1
- NR1H4
- TDP1
- SMN1
- SMAD3
- RORC
- PTH1R
- PPARD
- POLB
- NFE2L2
- AR
- MAPT
- LMNA
- GMNN
- GLP1R
- CYP3A4
- ATAD5
- TP53
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT2A
- ESRRA
- PRGR
- NOD1
- HSPB1
- HS90B
- HS90A
- GSK3A
- GCR
- DRD2
- ANDR
- CREB1
- CP3A4
- CP2CJ
- CP2C9
- CP1A2
- CP19A
- ATXN2
- SMAD2
Drug classes
- Estrogens
- Estrogens, Non-Steroidal
- Hormones
Cross-references
Synonyms
- Ralgro
- ralabol
- zearanol
- zearalanol
- (-)-.alpha.-zearalanol
- MK-188
- P-1496
- THFES (HM)
- Ralabol
- P 1496
- MK 188
- (-)-alpha-ZEARALANOL
- Zearalanol
- alpha zearalanol
- Zearanol
- alpha-Zeranol
- Zeranolum
- Frideron
- Xeranol
- DTXCID102315
- P1496
- Ralgro L. A.
- RefChem:56701
- MLS000081744
- SMR000060050
- a-Zeranol
- CHEBI:35064
- MK188
- Zeranol [USAN:INN:BAN]
- NCGC00037064-02
- Zeranolum [INN-Latin]
- Ralabol (TN)
- |A-Zearalanol
- Zeranol (USAN/INN)
- Alpha-Zeranol (1.0mg/ml in Acetonitrile)
- CAS-26538-44-3
- CCRIS 9234
- EINECS 247-769-0
Look up ZERANOL in the interactive SynDRA portal →